Dopaminergic therapy in aphasia

Aphasiology

Volumn 28, Issue 2, 2014, Pages 155-170

  Gill, Sumanjit K ^a   Leff, Alexander P ^b,c  

^a WATFORD GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aphasia; Bromocriptine; Dopamine; L dopa; Review

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PLACEBO; PRAMIPEXOLE; ROPINIROLE; SODIUM CHLORIDE;

ANOMIA; APHASIA; ARTICLE; CEREBROVASCULAR ACCIDENT; COGNITION; DISABILITY SEVERITY; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG PROGRAM; DRUG WITHDRAWAL; DYSTONIC DISORDER; HUMAN; LANGUAGE ABILITY; LEARNING; LOW DRUG DOSE; NAUSEA; OUTCOME ASSESSMENT; PARKINSON DISEASE; PERFORMANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPEECH AND LANGUAGE; TREATMENT OUTCOME; VERBAL BEHAVIOR;

EID: 84890352206     PISSN: 02687038     EISSN: 14645041     Source Type: Journal    
DOI: 10.1080/02687038.2013.802286     Document Type: Article

References (48)

1. Albert, M. L., Bachman, D. L., Morgan, A., & Helm-Estabrooks, N. (1988). Pharmacotherapy for aphasia. Neurology, 38, 877-879.
2. Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357-381.
3. Allen, L., Mehta, S., McClure, J. A., & Teasell, R. (2012). Therapeutic interventions for aphasia initiated more than six months post stroke: A review of the evidence. Top Stroke Rehabilitation, 19, 523-535.
4. Altman, D. G., & Bland, J. M. (1999). Statistics notes - how to randomise. British Medical Journal, 319, 703-704.
5. Altman, D. G., & Bland, J. M. (2005). Treatment allocation by minimisation. British Medical Journal, 330, 843.
6. Andersohn, F., & Garbe, E. (2009). Cardiac and noncardiac fibrotic reactions caused by Ergot-and Nonergot-derived dopamine agonists. Movement Disorders, 24, 129-133.
7. Ashtary, F., Janghorbani, M., Chitsaz, A., Reisi, M., & Bahrami, A. (2006). A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke. Neurology, 66, 914-916.
8. Benes, F. M. (2001). Carlsson and the discovery of dopamine. Trends Pharmacoogical Sciences, 22, 46-47.
9. Berthier, M. L. (1999). Transcortical motor aphasia. In M. L. Berthier (Ed.), Transcortical aphasias (37-74). Hove: Psychology Press.
10. Bragoni, M., Altieri, M., Di Piero, V., Padovani, A., Mostardini, C., & Lenzi, G. L. (2000). Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurological Sciences, 21, 19-22.
11. Civelli, O., Bunzow, J. R., & Grandy, D. K. (1993). Molecular diversity of the dopamine receptors. Annual Review of Pharmacology and Toxicology, 33, 281-307.
12. de Boissezon, X., Peran, P., de Boysson, C., & Demonet, J. F. (2007). Pharmacotherapy of aphasia: Myth or reality? Brain Language, 102, 114-125.
13. Dienes, Z. (2011). Bayesian versus orthodox statistics: Which side are you on? Perspectives on Psychological Science, 6, 274-290.
14. Dwan, K., Altman, D. G., Arnaiz, J. A., Bloom, J., Chan, A. W., Cronin, E.,. Williamson, P. R. (2008). Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE, 3, e3081. doi:10.1371/journal.pone.0003081
15. Edgington, E., & Onghena, P. (2007). Randomization tests (statistics: A series of textbooks and monographs) (4th ed.). Boca Raton, FL: Chapman & Hall/CRC.
16. Fiorillo, C. D., Tobler, P. N., & Schultz, W. (2003). Discrete coding of reward probability and uncertainty by dopamine neurons. Science, 299, 1898-1902.
17. Goberman, A. M., & Coelho, C. (2002). Acoustic analysis of parkinsonian speech I: Speech characteristics and L-Dopa therapy. NeuroRehabilitation, 17, 237-246.
18. Gold, M., VanDam, D., & Silliman, E. R. (2000). An open-label trial of bromocriptine in nonfluent aphasia: A qualitative analysis of word storage and retrieval. Brain Language, 74, 141-156.
19. Gorgoraptis, N., Mah, Y. H., Machner, B., Singh-Curry, V., Malhotra, P., Hadji-Michael, M.,. Husain, M. (2012). The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke. Brain, 135, 2478-2491.
20. Gotham, A. M., Brown, R. G., & Marsden, C. D. (1988). Frontal cognitive function in patients with Parkinsons-disease on and off Levodopa. Brain, 111, 299-321.
21. Greener, J., Enderby, P., & Whurr, R. (2001). Pharmacological treatment for aphasia following stroke. Cochrane Database Systematic Review, (4), CD000424. doi/10.1002/14651858.CD000424/abstract
22. Grossman, M., Glosser, G., Kalmanson, J., Morris, J., Stern, M. B., & Hurtig, H. I. (2001). Dopamine supports sentence comprehension in Parkinson's disease. Journal of the Neurological Sciences, 184, 123-130.
23. Gupta, S. R., & Mlcoch, A. G. (1992). Bromocriptine treatment of nonfluent aphasia. Archives of Physical Medicine and Rehabilitation, 73, 373-376.
24. Gupta, S. R., Mlcoch, A. G., Scolaro, C., & Moritz, T. (1995). Bromocriptine treatment of nonfluent aphasia. Neurology, 45, 2170-2173.
25. Gurden, H., Takita, M., & Jay, T. M. (2000). Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. Journal of Neuroscience, 20, RC106.
26. Hilliard, R. B. (1993). Single-case methodology in psychotherapy process and outcome research. Journal of Consulting and Clinical Psychology, 61, 373-380.
27. Husain, M., & Mehta, M. A. (2011). Cognitive enhancement by drugs in health and disease. Trends Cognitive Science, 15, 28-36.
28. Kertesz, A. (1982). The western aphasia battery. New York, NY: Grune and Stratton.
29. Knecht, S., Breitenstein, C., Bushuven, S., Wailke, S., Kamping, S., Floel, A.,. Ringelstein, E. B. (2004). Levodopa: Faster and better word learning in normal humans. Annals of Neurology, 56, 20-26.
30. Kvernmo, T., Hartter, S., & Burger, E. (2006). A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clinical Therapeurtics, 28, 1065-1078.
31. Lachin, J. M., Matts, J. P., & Wei, L. J. (1988). Randomization in clinical-trials - conclusions and recommendations. Controlled Clinical Trials, 9, 365-374.
32. Lazar, R. M., Minzer, B., Antoniello, D., Festa, J. R., Krakauer, J. W., & Marshall, R. S. (2010). Improvement in aphasia scores after stroke is well predicted by initial severity. Stroke, 41, 1485-1488.
33. Leemann, B., Laganaro, M., Chetelat-Mabillard, D., & Schnider, A. (2011). Crossover trial of subacute computerized aphasia therapy for anomia with the addition of either levodopa or placebo. Neurorehabil Neural Repair, 25, 43-47.
34. Levelt, W. J. M. (1999). Models of word production. Trends in Cognitive Neuroscience, 3, 223-232.
35. Lomas, J., & Kertesz, A. (1978). Patterns of spontaneous recovery in aphasic groups: A study of adult stroke patients. Brain Language, 5, 388-401.
36. MacLennan, D. L., Nicholas, L. E., Morley, G. K., & Brookshire, R. H. (1991). The effects of bromocriptine on speech and language function in a patient with transcortical motor aphasia. In T. E. Prescott (Ed.), Clinical Aphasiology (Vol. 20). Boston, MA: College Hill.
37. Missale, C., Nash, S. R., Robinson, S. W., Jaber, M., & Caron, M. G. (1998). Dopamine receptors: From structure to function. Physiogical Review, 78, 189-225.
38. Moss, A., & Nicholas, M. (2006). Language rehabilitation in chronic aphasia and time postonset: A review of single-subject data. Stroke, 37, 3043-3051.
39. Ozeren, A., Sarica, Y., Mavi, H., & Demirkiran, M. (1995). Bromocriptine is ineffective in the treatment of chronic nonfluent aphasia. Acta Neurologica Belgica, 95, 235-238.
40. Price, C. J., Seghier, M. L., & Leff, A. P. (2010). Predicting language outcome and recovery after stroke: The PLORAS system. Nature Reviews Neurology, 6, 202-210.
41. Quaglieri, C. E., & Celesia, G. G. (1977). Effect of Thalamotomy and Levodopa therapy on speech of Parkinson patients. European Neurology, 15, 34-39.
42. Raymer, A. M., Bandy, D., Adair, J. C., Schwartz, R. L., Williamson, D. J., Gonzalez Rothi, L. J., & Heilman, K. M. (2001). Effects of bromocriptine in a patient with crossed nonfluent aphasia: A case report. Archives of Physical Medicine and Rehabilitation, 82, 139-144.
43. Reed, D. A., Johnson, N. A., Thompson, C., Weintraub, S., & Mesulam, M. M. (2004). A clinical trial of bromocriptine for treatment of primary progressive aphasia. Annals of Neurology, 56, 750.
44. Sabe, L., Leiguarda, R., & Starkstein, S. E. (1992). An open-label trial of bromocriptine in nonfluent aphasia. Neurology, 42, 1637-1638.
45. Sabe, L., Salvarezza, F., Garcia Cuerva, A., Leiguarda, R., & Starkstein, S. (1995). A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology, 45, 2272-2274.
46. Seniow, J., Litwin, M., Litwin, T., Lesniak, M., & Czlonkowska, A. (2009). New approach to the rehabilitation of post-stroke focal cognitive syndrome: Effect of levodopa combined with speech and language therapy on functional recovery from aphasia. Journal of the Neurological Sciences, 283, 214-218.
47. Swinburn, K., Porter, G., & Howard, D. (2004). Comprehensive Aphasia Test. Hove: Psychology Press.
48. Williams, G. V., & Goldmanrakic, P. S. (1995). Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature, 376, 572-575.